Top Cited Articles

We are delighted to announce the 2017 impact factor for Thorax is 9.655 (Journal Citation Reports (c) Clarivate Analytics), and is placed 5th within the Respiratory Systems category. This is a testament to the vision of Editors-in-Chief Gisli Jenkins, Nicholas Hart and Alan Smyth and their team to serve the international research community by publishing the very best papers across respiratory medicine.

To mark this achievement we list below the 30 articles that have received the most citations over the past year and made them free to read:

2017

Chest electrical impedance tomography examination, data analysis, terminology, clinical use and recommendations: consensus statement of the TRanslational EIT developmeNt stuDy group
Frerichs I, Amato MBP, van Kaam AH, et al
10.1136/thoraxjnl-2016-208357

Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval
Yousaf-Khan U, van der Aalst C, de Jong PA, et al
10.1136/thoraxjnl-2016-208655

Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume
Kolb M, Richeldi L, Behr J, et al
10.1136/thoraxjnl-2016-208710

Physiotherapy, and speech and language therapy intervention for patients with refractory chronic cough: a multicentre randomised control trial
Chamberlain Mitchell SAF, Garrod R, Clark L, et al
10.1136/thoraxjnl-2016-208843

Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung
Segal LN, Clemente JC, Wu BG, et al
10.1136/thoraxjnl-2016-208599

Home-based rehabilitation for COPD using minimal resources: a randomised, controlled equivalence trial
Holland AE, Mahal A, Hill CJ, et al
10.1136/thoraxjnl-2016-208514

Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis
Alton EWFW, Beekman JM, Boyd AC, et al
10.1136/thoraxjnl-2016-208406

Different dyspnoea perception in COPD patients with frequent and infrequent exacerbations
Scioscia G, Blanco I, Arismendi E, et al
10.1136/thoraxjnl-2016-208332

The use of pretest probability increases the value of high-resolution CT in diagnosing usual interstitial pneumonia
Brownell R, Moua T, Henry TS, et al
10.1136/thoraxjnl-2016-209671

Bronchiectasis and the risk of cardiovascular disease: a population-based study
Navaratnam V, Millett ERC, Hurst JR, et al
10.1136/thoraxjnl-2015-208188

2016

Blood eosinophils and inhaled corticosteroid/long-acting beta-2 agonist efficacy in COPD
Pavord ID, Lettis S, Locantore N, et al
10.1136/thoraxjnl-2015-207021

Interobserver agreement for the ATS/ERS/JRS/ALAT criteria for a UIP pattern on CT
Walsh SLF, Calandriello L, Sverzellati N on behalf of The UIP Observer Consort, et al
10.1136/thoraxjnl-2015-207252

UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening
Field JK, Duffy SW, Baldwin DR, et al
10.1136/thoraxjnl-2015-207140

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
Floto RA, Olivier KN, Saiman L, et al
10.1136/thoraxjnl-2015-207360

Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis
Nathan SD, Albera C, Bradford WZ, et al
10.1136/thoraxjnl-2015-207011

International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety
Quittner AL, Abbott J, Georgiopoulos AM the International Committee on Mental Health, et al
10.1136/thoraxjnl-2015-207488

Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry
Sweeney J, Patterson CC, Menzies-Gow A on behalf of the British Thoracic Society Difficult Asthma Network, et al
10.1136/thoraxjnl-2015-207630

BTS/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults
Davidson AC, Banham S, Elliott M, et al
10.1136/thoraxjnl-2015-208209

Physical frailty and pulmonary rehabilitation in COPD: a prospective cohort study
Maddocks M, Kon SSC, Canavan JL, et al
10.1136/thoraxjnl-2016-208460

beta-Blockers are associated with a reduction in COPD exacerbations
Bhatt SP, Wells JM, Kinney GL For the COPDGene Investigators, et al
10.1136/thoraxjnl-2015-207251

2015

Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies
Hanania NA, Noonan M, Corren J, et al
10.1136/thoraxjnl-2014-206719

External validation of blood eosinophils, FENO and serum periostin as surrogates for sputum eosinophils in asthma
Wagener AH, de Nijs SB, Lutter R, et al
10.1136/thoraxjnl-2014-205634

British Thoracic Society guidelines for the investigation and management of pulmonary nodules
Callister MEJ, Baldwin DR, Akram AR, et al
10.1136/thoraxjnl-2015-207168

The clinical spectrum of pulmonary aspergillosis
Kosmidis C, Denning DW
10.1136/thoraxjnl-2014-206291

Asthma-COPD overlap 2015: now we are six
Gibson PG, McDonald VM
10.1136/thoraxjnl-2014-206740

Accelerated ageing of the lung in COPD: new concepts
Mercado N, Ito K, Barnes PJ
10.1136/thoraxjnl-2014-206084

Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis
DePianto DJ, Chandriani S, Abbas AR, et al
10.1136/thoraxjnl-2013-204596

Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease
Torres A, Blasi F, Dartois N, et al
10.1136/thoraxjnl-2015-206780

The cost of treating severe refractory asthma in the UK: an economic analysis from the British Thoracic Society Difficult Asthma Registry
O’Neill S, Sweeney J, Patterson CC, et al
10.1136/thoraxjnl-2013-204114

Characteristics of COPD in never-smokers and ever-smokers in the general population: results from the CanCOLD study
Tan WC, Sin DD, Bourbeau J, et al
10.1136/thoraxjnl-2015-206938